Clinical Trial Update: Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for methylnaltrexone in opioid-induced bowel dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowel Dysfunction

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Bowel Dysfunction | Phase 2 | Status: COMPLETED